Legal & General Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.3M Buy
129,567
+48,412
+60% +$2.35M ﹤0.01% 1436
2025
Q1
$2.76M Sell
81,155
-16,649
-17% -$567K ﹤0.01% 1805
2024
Q4
$3.85M Sell
97,804
-625
-0.6% -$24.6K ﹤0.01% 1704
2024
Q3
$4.62M Buy
98,429
+4,337
+5% +$204K ﹤0.01% 1609
2024
Q2
$5.08M Buy
94,092
+11,182
+13% +$604K ﹤0.01% 1518
2024
Q1
$5.65M Buy
82,910
+15,847
+24% +$1.08M ﹤0.01% 1449
2023
Q4
$4.2M Sell
67,063
-87
-0.1% -$5.45K ﹤0.01% 1613
2023
Q3
$3.05M Buy
67,150
+2,715
+4% +$123K ﹤0.01% 1698
2023
Q2
$3.62M Buy
64,435
+3,341
+5% +$188K ﹤0.01% 1634
2023
Q1
$2.76M Buy
61,094
+6,039
+11% +$273K ﹤0.01% 1730
2022
Q4
$2.24M Buy
55,055
+619
+1% +$25.2K ﹤0.01% 1830
2022
Q3
$3.56M Sell
54,436
-870
-2% -$56.8K ﹤0.01% 1550
2022
Q2
$3.36M Buy
55,306
+2,629
+5% +$160K ﹤0.01% 1615
2022
Q1
$3.31M Buy
52,677
+675
+1% +$42.4K ﹤0.01% 1758
2021
Q4
$3.94M Buy
52,002
+4,311
+9% +$327K ﹤0.01% 1694
2021
Q3
$5.34M Buy
47,691
+11,926
+33% +$1.33M ﹤0.01% 1514
2021
Q2
$5.79M Buy
35,765
+2,530
+8% +$410K ﹤0.01% 1469
2021
Q1
$4.05M Buy
33,235
+3,854
+13% +$470K ﹤0.01% 1674
2020
Q4
$4.5M Sell
29,381
-1,218
-4% -$187K ﹤0.01% 1509
2020
Q3
$2.56M Buy
30,599
+4,221
+16% +$353K ﹤0.01% 1667
2020
Q2
$1.94M Buy
26,378
+17,301
+191% +$1.27M ﹤0.01% 1745
2020
Q1
$428K Sell
9,077
-24,753
-73% -$1.17M ﹤0.01% 2114
2019
Q4
$2.06M Buy
33,830
+32,745
+3,018% +$1.99M ﹤0.01% 1786
2019
Q3
$44K Hold
1,085
﹤0.01% 2787
2019
Q2
$51K Buy
1,085
+545
+101% +$25.6K ﹤0.01% 2770
2019
Q1
$19K Hold
540
﹤0.01% 3109
2018
Q4
$15K Buy
540
+349
+183% +$9.69K ﹤0.01% 3179
2018
Q3
$8K Hold
191
﹤0.01% 3341
2018
Q2
$11K Buy
+191
New +$11K ﹤0.01% 3290